These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 27154995)
1. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis. Liao YJ; Jiang JR; Jin SQ Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995 [TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis. Kumar P; Rai V Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835 [TBL] [Abstract][Full Text] [Related]
3. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis. Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175 [TBL] [Abstract][Full Text] [Related]
4. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis. Su M; Song Y Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037 [TBL] [Abstract][Full Text] [Related]
5. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations. Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790 [TBL] [Abstract][Full Text] [Related]
6. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls. He XF; Wei W; Li SX; Su J; Zhang Y; Ye XH; Liu Y; Wang W Mol Biol Rep; 2012 Jun; 39(6):6811-23. PubMed ID: 22297695 [TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity. Wang M; Ma Y; Yuan W; Su K; Li MD J Neuroimmune Pharmacol; 2016 Sep; 11(3):434-45. PubMed ID: 26803486 [TBL] [Abstract][Full Text] [Related]
8. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis. Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589 [TBL] [Abstract][Full Text] [Related]
9. The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis. Xiao L; Tong M; Jin Y; Huang W; Li Z Mol Biol Rep; 2013 Feb; 40(2):1835-41. PubMed ID: 23096092 [TBL] [Abstract][Full Text] [Related]
10. No associations between five polymorphisms in COMT gene and migraine. Takigawa H; Kowa H; Nakashima K Acta Neurol Scand; 2017 Feb; 135(2):225-230. PubMed ID: 26988620 [TBL] [Abstract][Full Text] [Related]
11. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients. Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094 [TBL] [Abstract][Full Text] [Related]
12. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Rothe C; Koszycki D; Bradwejn J; King N; Deluca V; Tharmalingam S; Macciardi F; Deckert J; Kennedy JL Neuropsychopharmacology; 2006 Oct; 31(10):2237-42. PubMed ID: 16525418 [TBL] [Abstract][Full Text] [Related]
13. Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease. Liu J; Chen P; Guo M; Lu L; Li L Neurol Sci; 2015 Apr; 36(4):621-3. PubMed ID: 25367407 [TBL] [Abstract][Full Text] [Related]
14. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer. Chen Y; Yu X; Li T; Yan H; Mo Z Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785 [TBL] [Abstract][Full Text] [Related]
15. Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population. Liang S; Liu X; Fan P; Liu R; Zhang J; He G; Liu Y; Bai H Arch Med Res; 2012 Feb; 43(2):154-8. PubMed ID: 22475780 [TBL] [Abstract][Full Text] [Related]
16. Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis. Lee YH; Kim JH; Song GG Rheumatol Int; 2015 Jan; 35(1):159-66. PubMed ID: 24951880 [TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyltransferase Val158Met polymorphism (rs4680) is associated with pain in multiple sclerosis. Fernández-de-las-Peñas C; Ambite-Quesada S; Ortíz-Gutiérrez R; Ortega-Santiago R; Gil-Crujera A; Caminero AB J Pain; 2013 Dec; 14(12):1719-23. PubMed ID: 24290452 [TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease. Wu H; Dong F; Wang Y; Xiao Q; Yang Q; Zhao J; Quinn TJ; Chen SD; Liu J Parkinsonism Relat Disord; 2014 Oct; 20(10):1094-6. PubMed ID: 25108642 [TBL] [Abstract][Full Text] [Related]
19. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk. Tan X; Chen M Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560 [TBL] [Abstract][Full Text] [Related]
20. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. Costas J; Sanjuán J; Ramos-Ríos R; Paz E; Agra S; Ivorra JL; Páramo M; Brenlla J; Arrojo M J Psychiatr Res; 2011 Jan; 45(1):7-14. PubMed ID: 20488458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]